Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization.
Graves, B., Thompson, T., Xia, M., Janson, C., Lukacs, C., Deo, D., Di Lello, P., Fry, D., Garvie, C., Huang, K.S., Gao, L., Tovar, C., Lovey, A., Wanner, J., Vassilev, L.T.(2012) Proc Natl Acad Sci U S A 109: 11788-11793
- PubMed: 22745160 
- DOI: 10.1073/pnas.1203789109
- Primary Citation of Related Structures:  
3VBG, 3U15 - PubMed Abstract: 
Activation of p53 tumor suppressor by antagonizing its negative regulator murine double minute (MDM)2 has been considered an attractive strategy for cancer therapy and several classes of p53-MDM2 binding inhibitors have been developed. However, these ...